Rab8a 是一个关键的目标,即黑激素可以防止阿特拉辛引起的脂质障碍
Tian-Ning Yang1, Yu-Xiang Wang1, Ping-An Jian1
1College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, P.R. China.
Journal of agricultural and food chemistry
|October 9, 2024
概括
亚特拉辛除草剂破坏肝脏线粒体功能和脂质代谢. 黑色素通过恢复Rab8a来保护这种毒性,该Rab8a调节了线粒体中脂肪酸的使用.
科学领域:
- 环境毒理学环境毒理学
- 荷尔蒙的调节 荷尔蒙的调节
- 细胞代谢的细胞代谢.
背景情况:
- 阿特拉 (ATZ) 是一种被广泛使用的除草剂,已知会损害线粒体功能和脂质代谢.
- 一种荷尔蒙 - - 黑色素 (MLT) 显示出对抗线粒体功能障碍和脂质毒性的潜力.
- 需要阐明ATZ诱导的脂质毒性和MLT的保护作用的精确机制.
研究的目的:
- 调查ATZ诱导的肝细胞脂质代谢毒性背后的机制.
- 探索黑激素对ATZ诱导的细胞损伤的保护作用.
- 确定Rab8a在调解ATZ和MLT对线粒体功能和脂质代谢的影响中的作用.
主要方法:
- 动物研究:小鼠被分为控制,MLT,ATZ和ATZ+MLT组.
- 细胞研究:使用AML12细胞来分析MLT和Rab8a对ATZ破坏路径的影响.
- 分子分析:评估与线粒体功能和脂质代谢相关的mRNA和蛋白质水平.
主要成果:
- 在小鼠肝细胞和AML12细胞中,ATZ暴露引发了显著的线粒体应激,并破坏了脂肪酸代谢.
- 外源的MLT给药恢复了Rab8a水平,这反过来调节了线粒体脂肪酸利用率和整体线粒体功能.
- 单独准Rab8a并没有显著改变线粒体功能,但有效防止了肝细胞中ATZ诱导的脂质代谢障碍.
结论:
- 阿特拉会触发线粒体功能障碍,并破坏肝脏脂质代谢.
- 黑色素通过恢复Rab8a来减轻ATZ毒性,从而使线粒体脂肪酸代谢正常化.
- Rab8a是预防肝细胞中除草剂诱导的脂质代谢障碍的关键媒介.
更多相关视频
12:02Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
15.8K
05:59Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
2.3K
相关概念视频
01:19Management of Insomnia
234
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
234
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
149
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
149